Compare Inovio Pharmaceuticals Inc (INO) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Lockheed Martin Corporation — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Lockheed Martin Corporation trades at $507.08 (market cap $117.48B). The key difference: Lockheed Martin Corporation is far larger — about 1316× Inovio Pharmaceuticals Inc's market cap, and Lockheed Martin Corporation pays a 2.71% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | LMT | |
|---|---|---|
Market Cap | $89.27M | $117.48B |
Sector | Health | Industrials |
52-Week High | $2.87 | $676.70 |
52-Week Low | $1.05 | $410.74 |
Enterprise Value | $60.28M | $136.28B |
Dividend Yield | — | 2.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
